Tag: GSK

The collaboration settlement between GSK and Vir Biotechnology (Vir) has been amended, with Vir now persevering with to advance new ...

cagkansayin Pharma corporations have began 2023 with a bang, elevating costs of about 450 medicines this month, and extra value ...

JHVEPhoto GSK (NYSE:GSK) stated its drugs Jemperli (dostarlimab) met the primary purpose of progression-free survival (PFS) in sufferers with main ...